A Saudi Gastroenterology Association Position Statement on the Use of Tumor Necrosis Factor-alfa Antagonists for the Treatment of Inflammatory Bowel Disease

The objective of this position statement from the Saudi Gastroenterology Association is to guide gastroenterologists on the use of tumor necrosis factor-alfa (TNF-α) antagonists for the treatment of the idiopathic inflammatory bowel diseases, Crohn's disease, and ulcerative colitis. In this art...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosli, Mahmoud H., Al-Harbi, Othman, Feagan, Brian G., Almadi, Majid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Special Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542416/
https://www.ncbi.nlm.nih.gov/pubmed/26228361
http://dx.doi.org/10.4103/1319-3767.161635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542416/
https://www.ncbi.nlm.nih.gov/pubmed/26228361
http://dx.doi.org/10.4103/1319-3767.161635

Ejemplares similares